Weight Loss Guide • The Care Pharmacy
A clinically grounded guide to the top rated weight loss pills available in the UK, covering how each prescription treatment works, average weight loss outcomes, and how to choose the right option.
The weight loss supplement market is vast, loud, and largely unregulated — and for every genuinely effective prescription treatment, there are dozens of over-the-counter products making claims that the clinical evidence simply does not support. Navigating this landscape without a clear clinical framework is genuinely difficult, and patients who spend months trying ineffective supplements before accessing prescription treatment are unfortunately common. The top rated weight loss pills in the clinical sense — the treatments that have demonstrated meaningful, reproducible weight loss in well-designed trials and are licensed for use in the UK — are exclusively prescription medications: Mounjaro, Wegovy, Saxenda, and Orlistat. These are not supplements, they are not available without a clinical assessment, and the results they produce are fundamentally different in scale and consistency from anything available over the counter. At The Care Pharmacy, our prescribing team helps patients access clinically appropriate weight loss treatment quickly, confidentially, and entirely online — without a GP referral or in-person appointment.
Getting started is simpler than most patients expect — get in touch with our team if you have questions, or complete our online consultation to find out which weight loss treatment is right for you.
On this page
Quick Answer
The top rated weight loss pills and injections in the UK — based on clinical trial evidence and MHRA licensing — are Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda (liraglutide), and Orlistat, all of which require a prescription following a clinical assessment. Mounjaro is currently the most clinically effective option, producing average weight loss of up to 20.9% of body weight at the highest dose in clinical trials — results that rival bariatric surgery for many patients. Wegovy produces average weight loss of 14.9% and is now available as both a weekly injection and an oral tablet, making it the only GLP-1 weight loss medication currently available in pill form in the UK. Orlistat is the longest-established option, working differently from GLP-1 medications by blocking dietary fat absorption rather than suppressing appetite, and producing average weight loss of 5–7% of body weight when combined with dietary changes. All four treatments are available through The Care Pharmacy following a free, confidential online consultation.
Before covering the specific treatments, it is worth being direct about a distinction that the weight loss product market deliberately blurs: the difference between prescription weight loss medication and over-the-counter supplements.
Prescription weight loss medications are:
Over-the-counter weight loss supplements are:
This does not mean that every supplement is fraudulent — some have modest supporting evidence — but the scale and reliability of effect is categorically different from prescription treatment. A patient who could achieve 15–20% body weight loss on a licensed GLP-1 medication spending months on OTC supplements is not a well-informed patient.
Mounjaro is currently the most clinically effective weight loss treatment licensed for use in the UK. It is a dual GIP/GLP-1 receptor agonist — the first of its kind — meaning it activates two separate hormone receptor pathways simultaneously to produce appetite suppression, slowed gastric emptying, and improved metabolic function.
Key clinical facts:
Why patients rate it highly:
Patient reviews of Mounjaro consistently highlight profound appetite suppression, consistent weekly weight loss, and a qualitative shift in the relationship with food that makes dietary adherence significantly easier. The once-weekly injection schedule is widely praised for convenience, and the auto-injector pen design means the needle is never visible, which reduces anxiety for patients concerned about self-injection.
Wegovy is a GLP-1 receptor agonist containing semaglutide 2.4mg — the same active ingredient as Ozempic but at a higher dose licensed specifically for weight management. It has the most established clinical and real-world evidence base of any injectable weight loss medication currently available in the UK, with the STEP trial programme providing robust data across multiple patient populations.
Key clinical facts:
Why patients rate it highly:
Wegovy’s longer track record means patients can access a broader base of real-world experience when making their decision. The availability of an oral tablet — the Wegovy pill — makes it uniquely accessible for patients who are uncomfortable with self-injection or who simply prefer oral medication, opening up GLP-1 treatment to a group of patients who would previously have had no injectable alternative.
Beyond the clinical trial data, one of the most commonly reported patient experiences on GLP-1 medications is a profound reduction in food noise. Here is a closer look at how Wegovy and Mounjaro produce that effect:
@thecarepharmacyukDo you find yourself thinking about food daily? That constant chatter in your mind is called food noise. For some people, food noise is the endless thoughts about what to eat next, cravings, or feeling like food is always on their mind. In this video, our pharmacist Esther, talks about food noise and how it may be managed. Let us know if you’ve heard of food noise before.♬ original sound – TheCarePharmacy
Saxenda is a once-daily GLP-1 receptor agonist containing liraglutide 3mg. It is an older formulation than Mounjaro or Wegovy but has an extensive safety and efficacy record built over years of clinical use in the UK, and remains a clinically appropriate option for patients in whom the newer weekly injectables are not suitable.
Key clinical facts:
Why patients rate it:
Saxenda’s once-daily dosing means patients have more flexibility around timing relative to lifestyle factors. Its longer clinical history means prescribers and patients alike have a detailed understanding of its tolerability profile, and it remains an important option for patients who have not responded well to or are not suitable for the newer weekly GLP-1 medications.
Orlistat is the only prescription weight loss treatment in the UK that works through a fundamentally different mechanism from the GLP-1 medications. Rather than suppressing appetite centrally, Orlistat works in the digestive tract by inhibiting the enzyme lipase, blocking approximately one third of dietary fat from being absorbed. It is taken as a capsule three times daily with meals.
Key clinical facts:
Why patients rate it:
Orlistat is best rated by patients who approach it with a clear understanding of the dietary commitment it requires. For these patients — particularly those who prefer an oral medication and are committed to reducing dietary fat — it provides meaningful additional weight loss on top of dietary changes alone.
The table below compares the four licensed UK prescription weight loss treatments across the criteria that matter most when making a treatment decision:
Given the prominence of OTC weight loss products in online searches and pharmacy shelves, it is worth addressing them directly rather than simply dismissing them.
The most commonly sold OTC weight loss supplements in the UK include caffeine-based thermogenic products, glucomannan (a fibre-based appetite suppressant), green tea extract, CLA (conjugated linoleic acid), and various proprietary blends. The honest clinical picture:
The consistent picture across OTC supplements is that the most effective ones produce additional weight loss measured in fractions of a kilogram over several months — categorically different from the kilogram-per-week progress that many patients report on GLP-1 medications.
Patients who are spending significant sums on OTC supplements and finding results disappointing are not failing — they are using the wrong tools. Complete our online consultation to find out whether a prescription treatment is appropriate for your circumstances.
The right weight loss treatment is not the same for every patient — and choosing based on a single factor such as efficacy alone, or cost alone, often produces a suboptimal outcome. A clinical consultation that considers the full picture is the most reliable approach, but the following framework helps clarify where different treatments are most likely to be the best fit.
Mounjaro may be most appropriate when:
Wegovy may be most appropriate when:
Saxenda may be most appropriate when:
Orlistat may be most appropriate when:
Every patient’s circumstances are different — get in touch with our prescribing team to discuss which option is most appropriate for you.
These are the questions patients ask our prescribing team most often when researching the top rated weight loss pills available in the UK:
The most clinically effective weight loss treatments licensed in the UK are Mounjaro (tirzepatide) and Wegovy (semaglutide), both GLP-1 medications that produce average weight loss of 14–21% of body weight in clinical trials at their respective maintenance doses. Both require a prescription following a clinical assessment and are not available over the counter.
Alli (orlistat 60mg) is available over the counter from pharmacies for adults with a BMI of 28 or above, following a consultation with the pharmacist — it is the only weight loss medication available without a prescription in the UK. The Wegovy oral tablet and all other GLP-1 medications require a prescription following a full clinical assessment.
GLP-1 medications such as Mounjaro and Wegovy typically produce noticeable appetite suppression within the first one to two weeks, with measurable weight loss becoming apparent within the first month — with results accumulating progressively over the following months as doses increase. Orlistat begins reducing fat absorption from the first dose, with weight loss typically becoming measurable within the first four to twelve weeks of consistent use alongside a low-fat, calorie-reduced diet.
Orlistat is available on NHS prescription for eligible patients meeting specific BMI and clinical criteria through GP practices or structured weight management services, though access varies significantly by region. Mounjaro and Wegovy are available on the NHS in very limited circumstances through specialist weight management services — for most patients, private prescribing through a GPhC-registered online pharmacy remains the most accessible route.
Mounjaro, Wegovy, and Orlistat all have established safety profiles supported by clinical trial and real-world data, and long-term use is considered clinically appropriate for many patients — particularly those with obesity-related health conditions where sustained weight management offers significant health benefits. All prescription weight loss treatments should be used under the supervision of a qualified prescriber who conducts regular reviews to assess ongoing suitability, progress, and side effect management.
GLP-1 medications produce meaningful weight loss even without major dietary or exercise changes — the appetite suppression they provide creates a natural caloric deficit — but patients who make concurrent dietary improvements and increase physical activity consistently achieve significantly better and more sustainable outcomes than those who rely on medication alone. Orlistat requires active dietary fat restriction to be both effective and well tolerated, making dietary change a non-negotiable component of treatment rather than an optional enhancement.
The top rated weight loss pills in the UK are prescription medications — and the gap between what they can achieve and what OTC supplements can achieve is not a small one. Mounjaro, Wegovy, Saxenda, and Orlistat all have a legitimate clinical role, and choosing between them on the basis of a clear, individual clinical assessment produces fundamentally better outcomes than choosing based on marketing claims, price, or what worked for someone else.
Weight loss treatment has changed enormously in the last five years. The results that patients on Mounjaro and Wegovy are achieving — average weight loss approaching that of bariatric surgery, without the surgical risk or recovery — represent a genuine clinical step change. Patients who were previously told that surgery was their only option now have access to treatments that can deliver comparable outcomes through a weekly injection.
At The Care Pharmacy, our pharmacist-led prescribing team is here to help you access the right treatment for your circumstances — quickly, confidentially, and with the clinical support you deserve throughout. Whether you are starting your weight loss journey for the first time or looking for a more effective approach after previous attempts, our team is ready to help.
A better outcome starts with the right conversation — reach out to our prescribing team, or complete our online consultation to find out which weight loss treatment is right for you.
This article was written by Pharmacy Mentor and clinically reviewed by Mohammed Ismail Lakhi, MPharm, MRPharm, Superintendent Pharmacist at The Care Pharmacy. Mohammed is registered with the General Pharmaceutical Council (GPhC registration number 2072815) and leads clinical governance across The Care Pharmacy’s weight management services.
Last reviewed: August 2026
Disclaimer: This article is for general information only and is not a substitute for individual medical advice. Always consult a qualified prescriber before starting any prescription weight loss treatment.
Medically reviewed by
Superintendent Pharmacist
June 2026 · The Care Pharmacy · Clinically reviewed by Mohammed Ismail Lakhi MPharm, Superintendent Pharmacist The question coming up more and more: is there a pill version of Mounjaro or Wegovy? The short answer is – the Wegovy pill is available now in the UK. The landscape has moved fast, and understanding what’s available […]
Starting a new weight loss medication comes with questions, and if you have recently been prescribed Orlistat 120mg, understanding what to expect in the early weeks can make a significant difference to your experience. Most side effects are manageable with the right approach — and knowing how to combat them before they arise puts you […]
Clinically reviewed by Mohammed Ismail Lakhi, MPharm — Superintendent Pharmacist (GPhC reg. 2072815) Last updated: April 2026 Key points at a glance Orforglipron (brand name Foundayo) is the first small-molecule GLP-1 weight loss pill, developed by Eli Lilly — the same company behind Mounjaro. It received FDA approval on 1 April 2026 in the United […]
Orlistat is one of the most established prescription weight loss medications available in the UK. Despite its long history, many people still ask the same question: does Orlistat burn fat, or does it simply block fat absorption? A clear understanding of its mechanism can make it easier to manage expectations and optimise success. The Care […]
If you are exploring prescription weight management options and wondering whether Xenical or a weight loss injectable is right for you, our clinical team can help. At The Care Pharmacy, we offer a range of medically approved weight loss treatments, including Xenical and several injectable options. The right choice depends on your health profile, weight […]
If you are looking for a clinically supported way to lose weight, Orlistat can be a helpful option for many people in the UK. It is one of the most established prescription weight loss treatments and works differently to newer appetite-suppressing injections. Instead of changing hunger hormones, Orlistat helps reduce the amount of fat your […]
